Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Exosomes derived from mesenchymal stem cells primed with disease-condition-serum improved therapeutic efficacy in a mouse rheumatoid arthritis model via enhanced TGF-β1 production

Fig. 1

Immunophenotype and differentiation of immortalized mesenchymal stem cells (iMSCs) into adipocytes, osteocytes, and chondrocytes. A Immunophenotype of iMSCs B iMSC negative control, oil red-O stain × 100 C iMSCs that differentiated into adipocytes contained lipid droplets, oil red-O stain × 100 D iMSC negative control, Alizarin red S stain × 100 E iMSCs differentiated into osteocytes, Alizarin red S × 100; Scale bar = 100 μm F Aggregated chondrocytes derived from iMSCs, toluidine blue × 100; Scale bar = 100 μm G Aggregated chondrocytes derived from iMSCs, toluidine blue × 200; Scale bar = 50 μm

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512